Top View
- Leading Article Gut: First Published As 10.1136/Gut.39.6.784 on 1 December 1996
- Urticaria: Diagnostic and Treatment Considerations
- Modernized Reference Drug Program Histamine2 Receptor Blockers (H2 Blockers)
- A Rapid and Sensitive HPLC Method for Determination of Roxatidine in Human Plasma
- The Association Between Ranitidine Use and Gastrointestinal Cancers
- Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
- PRESCRIBING INFORMATION These Highlights Do Not Include All the Information Needed to Use ------CONTRAINDICATIONS------ONPATTRO® Safely and Effectively
- Influence of Histamine Receptor Antagonists on the Outcome of Perforated Appendicitis Analysis from a Prospective Trial
- Ranitidine, Famotidine, Andplacebo on Intragastric Acidity 83
- Potentially Harmful Drugs in the Elderly: Beers List and More
- Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Ranitidine Hydrochloride
- Diagnosis and Management of Anaphylaxis
- Product Monograph ZANTAC
- Neemmc Guidelines for Tablet Crushing and Administration Via Enteral Feeding Tubes
- Package Leaflet: Information for the User Ranitidine 150
- The Comparative Efficacy of Cimetidine and Ranitidine in Controlling Gastric
- Lafutidine 10 Mg Versus Rabeprazole 20 Mg in the Treatment of Patients with Heartburn-Dominant Uninvestigated Dyspepsia: a Randomized, Multicentric Trial
- Attachment 2
- Effects of Eight Weeks' Continuous Treatment with Oral Ranitidine and Cimetidine on Gastric Acid Secretion, Pepsin Secretion, and Fasting Serum Gastrin
- National Formulary Part I
- To Mix Or Not to Mix – Compatibilities of Parenteral Drug Solutions
- 2020 Ranitidine and Other Histamine-H2
- Risk Assessment of the Use of Ranitidine Products and Nizatidine Products in Which Carcinogenic Substance N-Nitrosodimethylamine Was Detected
- Neuropathic Pain Creon® (Pancreatin)
- Comparison of Twice-Daily Ranitidine with Standard Cimetidine Treatment
- Ranitidine (Withdrawn from US Market)
- Laryngopharyngeal Reflux Disease
- Apotex – Recall of Ranitidine
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances 2009
- Lafutidine Changes Levels of Somatostatin, Calcitonin Gene-Related Peptide, and Secretin in Human Plasma
- Association of Gastric Acid Suppression with Recurrent Clostridium Difficile Infection: a Systematic Review and Meta-Analysis
- Laboratory Analysis of Ranitidine and Nizatidine Products
- 2020 Table of Drugs
- Relationship Between Histamine2-Receptor Antagonist Medications and Risk of Invasive Breast Cancer
- Effect of Ranitidine Intake on the Risk of Gastric Cancer Development
- Formulation and Evaluation of Roxatidine Floating Tablets P
- United States Patent (19) 11 Patent Number: 4,824,664 Tarral Et Al
- H2-Antagonists (Cimetidine, Famotidine and Nizatidine)
- Guidelines for the Administration of Drugs Through Enteral Feeding Tubes
- Medications That Interfere with Allergy Testing
- Lafutidine 10Mg) in Patients with Acid Peptic Disorders in India
- ZANTAC™ Ranitidine Hydrochloride QUALITATIVE and QUANTITATIVE
- Female Breast Engorgement on Ranitidine a Case Report
- Drug Interactions of H2-Receptor Antagonists Involving Cytochrome
- Skin Testing Information Please Refrain from Using Any Fragrances